Niacinamide Market Size, Trends and Insights By Grade (Feed Grade, Pharmaceutical Grade), By Form (Liquid, Granular, Powder), By End-use (Cosmeceutical, Pharmaceutical, Animal Nutrition, Human Nutrition), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Drug stores and Retail Pharmacies) and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Report Snapshot
Study Period: | 2024-2033 |
Fastest Growing Market: | Asia-Pacific |
Largest Market: | Europe |
Major Players
- Lonza Group
- DSM
- Vanetta
- Vertellus
- Zhejiang Lanbo Biotechnology
- Merck KGaA
- Others
Reports Description
The Global Niacinamide Market was estimated at USD 725 million in 2022 and is anticipated to reach around USD 950 million by 2032, growing at a CAGR of roughly 3.5% between 2023 and 2032.
CMI research report offers a 360-degree view of the Niacinamide market’s drivers and restraints, coupled with the impact they have on demand during the projection period. Also, the report examines global opportunities and competitive analysis for the Niacinamide market.
- A form of vitamin B3 called nicotinamide, niacinamide, is essential for optimum health. A B3 shortage may result in problems with the skin, kidneys, or brain. Niacinamide use can prevent B3 deficiency. Depending on the criteria used, the organic molecule niacin, also known as nicotinic acid, is one of humans’ 20 to 80 essential nutrients. It is a component of the nicotinamide and niacin complexes. Its formula is C6H5NO2, and it belongs to the class of carboxylic acids called pyridines.
- For coenzymes such as nicotinamide adenine dinucleotide (NAD), NADH, NADP, and NADPH to operate, niacinamide, an active vitamin form B, is needed. It serves as a potent conditioning component in skin and hair care products and offers multifunctional benefits for skin care.
- By enhancing lipid component production, niacinamide also strengthens the structural integrity of the skin barrier and promotes skin homeostasis. Niacinamide is used more frequently in cosmetics and personal care products because of its ability to reduce wrinkles in mature skin, prevent photocarcinogenesis, and treat pigmentation issues.
- Supplementing human cells with niacinamide lengthens their reproductive lifetime and slows the onset of senescence. Additionally, it suppresses Nuclear Factor kappa B (NF-kB), lowers the production of the inflammatory cytokines IL-1 & IL-2, blocks mast cell degranulation, and slows leukocyte migration into the skin. Niacinamide improves the production of proteins and keratin, stimulates the production of ceramides, and speeds up the development of keratinocytes, all of which stabilize the function of the epidermal barrier.
- It smooths out wrinkles in aging skin, prevents photocarcinogenesis, and raises intracellular NADP levels. These considerations have increased the usage of niacinamide in cosmetic products used to treat skin conditions such as acne and problems of the epidermal barrier function. The preference for inexpensive, non-invasive ways to improve skin look is growing, the niacinamide industry is expected to rise as more over-the-counter treatments become available.
Report Scope
The global Niacinamide market research report offers an in-depth analysis of the global market size, which is further segmented into the regional and country-level market size, and segmentation market growth. Also, it provides market share, sales analysis, competitive landscape, the impact of domestic and global market participants, trade regulations, value chain optimization, recent key developments, strategic market growth analysis, opportunities analysis, product launches, and technological innovations. The scope of the study includes market sizing and forecast for segmentation by grade, form, end-use, and geography.
Feature of the Report | Details |
Market Size in 2023 | USD 747 Million |
Projected Market Size in 2032 | USD 950 Million |
Market Size in 2022 | USD 725 Million |
CAGR Growth Rate | 3.5% CAGR |
Base Year | 2023 |
Forecast Period | 2024-2033 |
Key Segment | By Grade, Form, By End-use, By Distribution Channel and Region |
Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Key Market Dynamics
- During the forecast period of 2023–2032, the niacinamide market is expected to grow at a faster rate due to rising demand for the product due to its health benefits, such as maintaining cholesterol levels and vitamin B3 levels in the body, increasing usage in skin care cosmetics, increasing consumer awareness of the consumption of healthy food supplements, and improving energy metabolism. On the other hand, the growth of the healthcare and cosmetics sectors would increase opportunities for the niacinamide market to grow throughout the projected time.
- Niacinamide is used more frequently in cosmetics and personal care products because it reduces wrinkles in mature skin, prevents photocarcinogenesis, and treats pigmentation issues. In recent years, Niacinamide has undergone extensive research and development to examine its potential for treating and preventing non-melanoma malignancies. This factor is expected to fuel future revenue growth in this market.
- Niacinamide plays a significant role in modulating the efficiency of transcription, DNA repair, and cellular energy metabolism. It is widely used in anti-acne, skin whitening, and skin rejuvenation treatments due to its anti-inflammatory and sebostatic qualities, which lower free radical levels in the body and sebum excretion on the face. Additionally, increasing the amount of niacinamide added to animal feed to prevent vitamin B3 deficiency and related illnesses in cattle is projected to promote market expansion.
- The pharmaceutical-grade niacinamide market is anticipated to have the largest revenue share over the forecast period due to rising demand for cosmeceuticals to treat skin conditions and diseases, the development of potent anti-aging treatments, and the prevention of vitamin B3 deficiency. Throughout the forecast period, the growing use of granular niacinamide in manufacturing vitamin B3 nutritional supplements, such as tablets and hard-shell capsules, animal feed fortification, and cosmetics, is anticipated to propel revenue growth in the granular sector.
Pharmaceutical Grade to Hold the Significant Market Share in the Niacinamide Market in 2022
- The worldwide niacinamide market has been divided into pharmaceutical grade and feed grade based on grade. Due to rising demand for pharmaceutical-grade niacinamide in the manufacturing of cosmeceuticals and pharmaceutical products and the development of therapeutics for autoimmune and other skin disorders, the pharmaceutical-grade segment is anticipated to hold the largest revenue share in the global market throughout the forecast period.
- Another important element influencing the growth of this segment’s revenue is the affordability of pharmaceutical-grade niacinamide and high-quality nutraceuticals. This grade of niacinamide is utilized as a pharmaceutical reference standard for measuring an analyte concentration in plasma, pharmaceutical formulations, and nutritional formula powders.
- As niacinamide is increasingly supplemented in animal feed to promote weight increase, feed intake optimization, nutrient absorption, and general livestock health, the feed grade segment is anticipated to maintain a consistent market share over the projection period. Niacinamide supplementation is a useful source of niacin for animal nutrition. It can aid in preventing health issues linked to vitamin B3 insufficiency, which is anticipated to further increase the demand for feed-grade niacinamide.
Competitive Landscape
The existence of numerous competitors operating on a global and regional scale has led to the fragmentation of the niacinamide market worldwide. Key companies are working on new products and forming alliances to meet the expanding worldwide demand and establish a solid foothold in the market.
The competitive landscape of the Niacinamide industry gives information about the competitors. The company’s financials, revenue generated, market potential, investment in R&D, global presence, new market initiatives, production capacities, production sites and facilities, company strengths and weaknesses, product release, product width and breadth, and application dominance are among the details that are included. The data points mentioned above only pertain to the companies’ market focus on Niacinamide manufacturing.
- 2021: Niacinamide-peptides, known as Fision GlowPlex, were developed by TRI-K Industries, Inc. to improve skin radiance, support uniform skin tone, blur facial flaws, and lessen the visibility of hyperpigmentation and dark spots.
List of the prominent players in the global Niacinamide market:
- Lonza Group
- DSM
- Vanetta
- Vertellus
- Zhejiang Lanbo Biotechnology
- Merck KGaA
- Evonik Industries AG
- Foodchem International Corporation
- Koninklijke DSM N.V.
- BASF SE
- Bactolac Pharmaceutical Inc.
- Lasons India.
- Foodchem International Corporation
- Others
The global Niacinamide market is segmented as follows:
By Grade
- Feed Grade
- Pharmaceutical Grade
By Form
- Liquid
- Granular
- Powder
By End-use
- Cosmeceutical
- Pharmaceutical
- Animal Nutrition
- Human Nutrition
By Distribution Channel
- Hospital Pharmacies
- Online Pharmacies
- Drug stores and Retail Pharmacies
By Region
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Niacinamide Market, (2024 – 2030) (USD Million)
- 2.2 Global Niacinamide Market : snapshot
- Chapter 3. Global Niacinamide Market – Industry Analysis
- 3.1 Niacinamide Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Growing number of clinical research projects investigating niacinamide’s uses in medicine and cosmetics
- 3.2.2 Demand as senior people emphasize improving aesthetic appearance and need to maintain skin health.
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Grade
- 3.7.2 Market attractiveness analysis By Form
- 3.7.3 Market attractiveness analysis By End-use
- Chapter 4. Global Niacinamide Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Niacinamide Market: company market share, 2022
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Niacinamide Market – Grade Analysis
- 5.1 Global Niacinamide Market overview: By Grade
- 5.1.1 Global Niacinamide Market share, By Grade, 2022 and 2030
- 5.2 Feed Grade
- 5.2.1 Global Niacinamide Market by Feed Grade, 2024 – 2030 (USD Million)
- 5.3 Pharmaceutical Grade
- 5.3.1 Global Niacinamide Market by Pharmaceutical Grade, 2024 – 2030 (USD Million)
- 5.1 Global Niacinamide Market overview: By Grade
- Chapter 6. Global Niacinamide Market – Form Analysis
- 6.1 Global Niacinamide Market overview: By Form
- 6.1.1 Global Niacinamide Market share, By Form, 2022 and 2030
- 6.2 Liquid
- 6.2.1 Global Niacinamide Market by Liquid, 2024 – 2030 (USD Million)
- 6.3 Granular
- 6.3.1 Global Niacinamide Market by Granular, 2024 – 2030 (USD Million)
- 6.4 Powder
- 6.4.1 Global Niacinamide Market by Powder, 2024 – 2030 (USD Million)
- 6.1 Global Niacinamide Market overview: By Form
- Chapter 7. Global Niacinamide Market – End-use Analysis
- 7.1 Global Niacinamide Market overview: By End-use
- 7.1.1 Global Niacinamide Market share, By End-use, 2022 and 2030
- 7.2 Cosmeceutical
- 7.2.1 Global Niacinamide Market by Cosmeceutical, 2024 – 2030 (USD Million)
- 7.3 Pharmaceutical
- 7.3.1 Global Niacinamide Market by Pharmaceutical , 2024 – 2030 (USD Million)
- 7.4 Animal Nutrition
- 7.4.1 Global Niacinamide Market by Animal Nutrition, 2024 – 2030 (USD Million)
- 7.5 Human Nutrition
- 7.5.1 Global Niacinamide Market by Human Nutrition, 2024 – 2030 (USD Million)
- 7.1 Global Niacinamide Market overview: By End-use
- Chapter 8. Niacinamide Industry – Regional Analysis
- 8.1 Global Niacinamide Industry Regional Overview
- 8.2 Global Niacinamide Industry Share, by Region, 2022 & 2030 (USD Million)
- 8.3. North America
- 8.3.1 North America Niacinamide Industry, 2024 – 2030 (USD Million)
- 8.3.1.1 North America Niacinamide Industry, by Country, 2024 – 2030 (USD Million)
- 8.3.1 North America Niacinamide Industry, 2024 – 2030 (USD Million)
- 8.4 North America Niacinamide Industry, by Grade, 2024 – 2030
- 8.4.1 North America Niacinamide Industry, by Grade, 2024 – 2030 (USD Million)
- 8.5 North America Niacinamide Industry, by Form, 2024 – 2030
- 8.5.1 North America Niacinamide Industry, by Form, 2024 – 2030 (USD Million)
- 8.6 North America Niacinamide Industry, by End-use, 2024 – 2030
- 8.6.1 North America Niacinamide Industry, by End-use, 2024 – 2030 (USD Million)
- 8.7. Europe
- 8.7.1 Europe Niacinamide Industry, 2024 – 2030 (USD Million)
- 8.7.1.1 Europe Niacinamide Industry, by Country, 2024 – 2030 (USD Million)
- 8.7.1 Europe Niacinamide Industry, 2024 – 2030 (USD Million)
- 8.8 Europe Niacinamide Industry, by Grade, 2024 – 2030
- 8.8.1 Europe Niacinamide Industry, by Grade, 2024 – 2030 (USD Million)
- 8.9 Europe Niacinamide Industry, by Form, 2024 – 2030
- 8.9.1 Europe Niacinamide Industry, by Form, 2024 – 2030 (USD Million)
- 8.10 Europe Niacinamide Industry, by End-use, 2024 – 2030
- 8.10.1 Europe Niacinamide Industry, by End-use, 2024 – 2030 (USD Million)
- 8.11. Asia Pacific
- 8.11.1 Asia Pacific Niacinamide Industry, 2024 – 2030 (USD Million)
- 8.11.1.1 Asia Pacific Niacinamide Industry, by Country, 2024 – 2030 (USD Million)
- 8.11.1 Asia Pacific Niacinamide Industry, 2024 – 2030 (USD Million)
- 8.12 Asia Pacific Niacinamide Industry, by Grade, 2024 – 2030
- 8.12.1 Asia Pacific Niacinamide Industry, by Grade, 2024 – 2030 (USD Million)
- 8.13 Asia Pacific Niacinamide Industry, by Form, 2024 – 2030
- 8.13.1 Asia Pacific Niacinamide Industry, by Form, 2024 – 2030 (USD Million)
- 8.14 Asia Pacific Niacinamide Industry, by End-use, 2024 – 2030
- 8.14.1 Asia Pacific Niacinamide Industry, by End-use, 2024 – 2030 (USD Million)
- 8.15. Latin America
- 8.15.1 Latin America Niacinamide Industry, 2024 – 2030 (USD Million)
- 8.15.1.1 Latin America Niacinamide Industry, by Country, 2024 – 2030 (USD Million)
- 8.15.1 Latin America Niacinamide Industry, 2024 – 2030 (USD Million)
- 8.16 Latin America Niacinamide Industry, by Grade, 2024 – 2030
- 8.16.1 Latin America Niacinamide Industry, by Grade, 2024 – 2030 (USD Million)
- 8.17 Latin America Niacinamide Industry, by Form, 2024 – 2030
- 8.17.1 Latin America Niacinamide Industry, by Form, 2024 – 2030 (USD Million)
- 8.18 Latin America Niacinamide Industry, by End-use, 2024 – 2030
- 8.18.1 Latin America Niacinamide Industry, by End-use, 2024 – 2030 (USD Million)
- 8.19. The Middle-East and Africa
- 8.19.1 The Middle-East and Africa Niacinamide Industry, 2024 – 2030 (USD Million)
- 8.19.1.1 The Middle-East and Africa Niacinamide Industry, by Country, 2024 – 2030 (USD Million)
- 8.19.1 The Middle-East and Africa Niacinamide Industry, 2024 – 2030 (USD Million)
- 8.20 The Middle-East and Africa Niacinamide Industry, by Grade, 2024 – 2030
- 8.20.1 The Middle-East and Africa Niacinamide Industry, by Grade, 2024 – 2030 (USD Million)
- 8.21 The Middle-East and Africa Niacinamide Industry, by Form, 2024 – 2030
- 8.21.1 The Middle-East and Africa Niacinamide Industry, by Form, 2024 – 2030 (USD Million)
- 8.22 The Middle-East and Africa Niacinamide Industry, by End-use, 2024 – 2030
- 8.22.1 The Middle-East and Africa Niacinamide Industry, by End-use, 2024 – 2030 (USD Million)
- Chapter 9. Company Profiles
- 9.1 Lonza Group
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 DSM
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Vanetta
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Vertellus
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Zhejiang Lanbo Biotechnology
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Merck KGaA
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Evonik Industries AG
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Foodchem International Corporation
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Koninklijke DSM N.V.
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 BASF SE
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 Bactolac Pharmaceutical Inc.
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Lasons India.
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 Foodchem International Corporation
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 Others.
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.1 Lonza Group
List Of Figures
Figures No 1 to 25
List Of Tables
Tables No 1 to 77
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2030
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
Perspective | Primary research | Secondary research |
Supply-side |
|
|
Demand-side |
|
|
Market Analysis Matrix
Qualitative analysis | Quantitative analysis |
|
|
Prominent Players
- Lonza Group
- DSM
- Vanetta
- Vertellus
- Zhejiang Lanbo Biotechnology
- Merck KGaA
- Evonik Industries AG
- Foodchem International Corporation
- Koninklijke DSM N.V.
- BASF SE
- Bactolac Pharmaceutical Inc.
- Lasons India.
- Foodchem International Corporation
- Others
FAQs
“North America” region will lead the global Niacinamide market during the forecast period 2023 to 2032.
The key factors driving the market are growing number of clinical research projects investigating niacinamide’s uses in medicine and cosmetics and demand as senior people emphasize improving aesthetic appearance and need to maintain skin health.
The key players operating in the Niacinamide market are Lonza Group, DSM, Vanetta, Vertellus, Zhejiang Lanbo Biotechnology, Merck KGaA, Evonik Industries AG, Foodchem International Corporation, Koninklijke DSM N.V., BASF SE, Bactolac Pharmaceutical Inc., Lasons India., Foodchem International Corporation, Others.
The global Niacinamide market is expanding growth with a CAGR of approximately 3.5% during the forecast period (2023 to 2032).
The global Niacinamide market size was valued at USD 725 Million in 2022 and it is projected to reach around USD 950 Million by 2032.